HUE053554T2 - Eljárás 1-(arilmetil)-kinazolin-2,4-(1H, 3H)-dion elõállítására - Google Patents

Eljárás 1-(arilmetil)-kinazolin-2,4-(1H, 3H)-dion elõállítására

Info

Publication number
HUE053554T2
HUE053554T2 HUE17773281A HUE17773281A HUE053554T2 HU E053554 T2 HUE053554 T2 HU E053554T2 HU E17773281 A HUE17773281 A HU E17773281A HU E17773281 A HUE17773281 A HU E17773281A HU E053554 T2 HUE053554 T2 HU E053554T2
Authority
HU
Hungary
Prior art keywords
arylmethyl
quinazoline
dione
manufacturing process
manufacturing
Prior art date
Application number
HUE17773281A
Other languages
English (en)
Inventor
Suixiong Cai
Original Assignee
Impact Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Impact Therapeutics Inc filed Critical Impact Therapeutics Inc
Publication of HUE053554T2 publication Critical patent/HUE053554T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HUE17773281A 2016-04-01 2017-03-31 Eljárás 1-(arilmetil)-kinazolin-2,4-(1H, 3H)-dion elõállítására HUE053554T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610202881 2016-04-01

Publications (1)

Publication Number Publication Date
HUE053554T2 true HUE053554T2 (hu) 2021-07-28

Family

ID=59963547

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17773281A HUE053554T2 (hu) 2016-04-01 2017-03-31 Eljárás 1-(arilmetil)-kinazolin-2,4-(1H, 3H)-dion elõállítására

Country Status (13)

Country Link
US (1) US10562889B2 (hu)
EP (1) EP3438096B1 (hu)
CN (1) CN109153652B (hu)
CY (1) CY1123898T1 (hu)
DK (1) DK3438096T3 (hu)
ES (1) ES2859460T3 (hu)
HR (1) HRP20210328T1 (hu)
HU (1) HUE053554T2 (hu)
PL (1) PL3438096T3 (hu)
PT (1) PT3438096T (hu)
RS (1) RS61556B1 (hu)
SI (1) SI3438096T1 (hu)
WO (1) WO2017167251A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116322680A (zh) * 2020-07-24 2023-06-23 上海瑛派药业有限公司 Parp抑制剂的联合用药方案
WO2022099442A1 (zh) * 2020-11-10 2022-05-19 上海瑛派药业有限公司 5-氟-1-(4-氟-3-(4-(嘧啶-2-基)哌嗪-1-羰基)苄基)喹唑啉-2,4(1h,3h)-二酮的结晶形式及其制备

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006522109A (ja) * 2003-03-31 2006-09-28 大正製薬株式会社 新規なキナゾリン誘導体及びそれらの使用に関連する治療方法
MXPA06014541A (es) * 2004-06-30 2007-03-23 Janssen Pharmaceutica Nv Derivados de quinazolindiona como inhibidores de la poli(adp-ribosa) polimerasa.
AU2005282761B2 (en) * 2004-09-02 2012-02-02 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CN101475537A (zh) * 2009-01-07 2009-07-08 太仓市浦源化工有限公司 一种2,4-二氯喹唑啉的制备方法
CN103443085B (zh) * 2011-03-14 2016-03-23 南京英派药业有限公司 喹唑啉二酮及其应用
TWI527800B (zh) 2011-04-01 2016-04-01 南京英派藥業有限公司 作為聚(二磷酸腺苷酸-核醣)聚合酶(parp)之抑制劑之1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮及其應用
US9102631B2 (en) * 2011-11-01 2015-08-11 Impact Therapeutics, Inc. 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
DK3278803T3 (da) * 2015-04-03 2022-08-29 Impact Therapeutics Shanghai Inc Fast farmaceutisk doseringsform af PARP-inhibitor, og anvendelse af fast farmaceutisk doseringsform af PARP-inhibitor
US20190006601A1 (en) * 2015-12-21 2019-01-03 Idemitsu Kosan Co., Ltd. Nitrogen-containing heterocyclic compounds and organic electroluminescence devices containing them

Also Published As

Publication number Publication date
RS61556B1 (sr) 2021-04-29
WO2017167251A1 (zh) 2017-10-05
CN109153652B (zh) 2021-07-27
PL3438096T3 (pl) 2021-05-17
EP3438096A1 (en) 2019-02-06
CY1123898T1 (el) 2022-05-27
US20190112298A1 (en) 2019-04-18
US10562889B2 (en) 2020-02-18
ES2859460T3 (es) 2021-10-04
EP3438096A4 (en) 2019-08-21
CN109153652A (zh) 2019-01-04
DK3438096T3 (da) 2021-02-22
HRP20210328T1 (hr) 2021-04-02
EP3438096B1 (en) 2020-12-02
SI3438096T1 (sl) 2021-04-30
PT3438096T (pt) 2021-03-03

Similar Documents

Publication Publication Date Title
GB2587562B (en) Textiles and articles, and processes for making the same
ZA202004692B (en) Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
PL3555074T3 (pl) Aminopirazole jako selektywne inhibitory kinaz janusowych
SI3227297T1 (sl) 4,6-substituirani-pirazolo(1,5-A)pirazini kot inhibitorji Janus kinaze
EP3437751A4 (en) METHOD FOR MANUFACTURING AN ARTICLE FORMED IN THE PRESS
IL248272B (en) A new manufacturing process for triazine, pyrimidine and pyridine derivatives
ZA202002530B (en) Process for producing herbicidal pyridazinone compounds
IL292429B1 (en) An improved process for the preparation of aminopyrimidine derivatives
GB2574751B (en) Technique for forming porous fibers
RS61556B1 (sr) Postupak dobijanja 1-(arilmetil) hinazolin-2,4 (1h, 3h)-diona
IL283085A (en) Improved T cell production process
IL261225B (en) Derivative-5-methyl-6-phenyl-4,5-dihydro-h2-pyridazine-3-one
EP3419627C0 (en) PROCESS FOR MANUFACTURING ANTIVIRAL COMPOUNDS, SUCH AS TRIAZAVIRINE
GB201804887D0 (en) Novel electrochemical set-up for ammonia production
SI3621966T1 (sl) Derivati pirazol(1,5-A)pirimidina kot kinazni JAK inhibitorji
HUE054849T2 (hu) Eljárás formaldehid-stabilizált karbamid gyártására
PL3551670T3 (pl) Proces wytwarzania polietylenu
HUE049807T2 (hu) Módszer izocianátok elõállítására szolgáló eljárás kontrollálására